<DOC>
	<DOCNO>NCT00547781</DOCNO>
	<brief_summary>The aim study perform randomize control trial evaluate usefulness preimplantation genetic diagnosis ( PGD ) patient repetitive implantation failure . Patients prospectively randomize two group : standard IVF blastocyst transfer day-5 transfer day-5 PGD aneuploidy screen chromosome 13 , 15 , 16 , 18 , 21 , 22 , X Y . The end point study : Cancellation rate ; implantation rate ongoing implantation rate . Inclusion criterion : patient ≥2 previous IVF failure without clinical biochemical pregnancy transfer least 2 good quality embryos per transfer . Exclusion criterion uterine abnormality , abnormal karyotype , abnormal result thrombophilia screen low responder patient ( less 4 expect oocyte ) .</brief_summary>
	<brief_title>Implantation Failure PGD</brief_title>
	<detailed_description />
	<criteria>Patients age ≥2 previous cycle , negative TIG biochemical pregnancy fresh transfer least 2 embryos cycle . Patients PGD indication ( age , repetitive miscarriage , chromosomal anomaly , etc . ) Patients ectopic pregnancy previous cycle . Recipient oocyte donation . Patients 4 less oocyte retrieve .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>